Author: Customer Service

SOUTH SAN FRANCISCO, Calif., March 17, 2026 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq:CTMX), a leader in the field of masked, conditionally activated biologics, today announced the pricing of an underwritten public offering of 45,990,567 shares of its common stock at a price to the public of $5.30 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 1,179,245 shares of common stock. The gross proceeds to CytomX from the offering are expected to be $250 million, before deducting underwriting discounts and commissions and estimated offering expenses. In addition, CytomX granted the underwriters a 30-day option to purchase up to an additional 7,075,471 shares of its common stock at the public offering price, less underwriting discounts and commissions. The closing of the offering is...

MIAMI, March 17, 2026 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced the pricing of an underwritten public offering of 19,324,677 shares of its common stock at a public offering price of $3.85 per share, and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to 2,753,246 shares of common stock at a public offering price of $3.8499 per pre-funded warrant, which represents the per share public offering price less the $0.0001 per share exercise price for each pre-funded warrant. Gross proceeds from the offering are expected to be approximately $85 million, before deducting underwriting discounts and commissions and...

VANCOUVER, British Columbia, March 17, 2026 (GLOBE NEWSWIRE) — Eco Oro Minerals Corp. (CSE: EOM) (“Eco Oro” or the “Company”) announces it has completed the second tranche of a previously announced private placement (the “Private Placement”) of 2025 contingent value rights certificates (“2025 CVRs”). The Private Placement was completed in two tranches: (i) a first tranche of US$4,000,000 of 2025 CVRs completed on August 7, 2025 and (ii) a second tranche of US$500,000 of 2025 CVRs completed on March 16, 2026. The proceeds of the Private Placement will be principally used to support the Company’s application to annul the damages award issued on July 15, 2024 awarding no monetary compensation to the Company by the arbitral tribunal constituted under the International Centre for Settlement of Investment Disputes in its arbitration proceedings...

ROCKVILLE, Md. and SUZHOU, China, March 17, 2026 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced that four abstracts highlighting the latest preclinical results from its pipeline programs have been selected for poster presentations at the American Association of Cancer Research (AACR) Annual Meeting 2026, taking place April 17-22, 2026, in San Diego, CA, USA. The data to be presented encompasses three of the Company’s novel drug candidates: BCR-ABL tyrosine kinase inhibitor Olverembatinib (HQP1351), FAK/ALK/ROS1 tyrosine kinase inhibitor APG-2449, and PRC2/EED inhibitor APG-5918. The AACR...

Live Demos Feature SmartSwitch.ai, SmartEdge AI Gateways and FLIR-Integrated Drone Intelligence Alongside Lantronix’s Industry-Leading PoE Switching Solutions for Security, Industrial and Smart City Networks IRVINE, Calif., March 17, 2026 (GLOBE NEWSWIRE) — Lantronix Inc. (Nasdaq: LTRX), a global provider of Edge AI and Industrial IoT solutions that power NDAA-compliant unmanned systems, critical infrastructure and resilient enterprise networks, today announced it will showcase its latest intelligent switching and edge computing platforms at ISC West, held March 25–27 in Las Vegas, at booth 34073. Demonstrations will feature its new SmartSwitch.ai platform, SmartEdge gateways and its industry‑leading Power over Ethernet (PoE) switches and media converters, including solutions from Transition Networks, now part of Lantronix. ISC...

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host its inaugural R&D Day on Wednesday, April 8, 2026 in New York City. The event will be webcast live from 8:00am to 11:00am EST and will include presentations from Mesoblast’s senior leadership team and from key opinion leaders. The event will include discussions regarding the company’s corporate strategy, successful commercialization of its flagship product Ryoncil®, and its robust multi-billion-dollar pipeline opportunities in inflammatory pain and cardiovascular disease. In addition, the company will unveil new technology that will drive innovation for the next era of cellular medicines. Dr. Silviu Itescu, Chief Executive of Mesoblast, said: ”Our inaugural...

VANCOUVER, British Columbia, March 17, 2026 (GLOBE NEWSWIRE) — Swiss Water Decaffeinated Coffee Inc. (the “Company”) (TSX:SWP) announces that its Board of Directors (the “Board”) has approved the adoption of a Shareholder Rights Plan, pursuant to a Shareholder Rights Plan Agreement entered into with Computershare Investor Services Inc., as Rights Agent, dated and effective March 17, 2026. The Shareholder Rights Plan is similar to modern rights plans adopted by other Canadian public companies. It was not adopted in response to any specific proposal or intention to acquire control of the Company. The Shareholder Rights Plan will provide the Board and shareholders of the Company with adequate time to consider and evaluate proposals and enable the Board to consider alternatives to ensure shareholders receive full and fair value for their...

SAN JOSE, Calif., March 17, 2026 (GLOBE NEWSWIRE) — On Friday, March 13, 2026, the California Public Utilities Commission issued a proposed decision (PD) on the 2024 General Rate Case of California Water Service (2024 California GRC), the largest subsidiary of California Water Service Group (Company or Group, NYSE:CWT). The PD authorizes additional revenues of $92.3 million in 2026 (a rate increase of 11.1%); $50.8 million in 2027 (a rate increase of 5.5%); and $52.4 million in 2028 (a rate increase of 5.4%). The final infrastructure investment budget for 2025 through 2027 was not included in the PD; however, the Company anticipates it will be provided as an attachment to the final decision. Although the PD does not authorize the Company’s request to decouple sales from revenues to promote conservation and lower water rates for...

SAN FRANCISCO, March 17, 2026 (GLOBE NEWSWIRE) — The RealReal (Nasdaq: REAL)—the world’s largest online marketplace for authenticated, resale luxury goods—today announced that Ajay Gopal, the company’s Chief Financial Officer, will participate in a fireside chat at the 38th Annual Roth Conference on Monday, March 23. Mr. Gopal is scheduled to present at 3:00pm PT (6:00pm ET). Registration for the live webcast is available on The RealReal’s investor website at https://investor.therealreal.com/. A replay will be available for 90 days following the event. About The RealReal Inc.The RealReal is the world’s largest online marketplace for authenticated, resale luxury goods, trusted by more than 40 million members. Our full-service consignment model—offering virtual appointments, in-home pickup, drop-off, and direct shipping—enables consumers...

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) — Gemini Space Station, Inc. (“Gemini”) (NASDAQ: GEMI), a global crypto and prediction markets platform, today announced an update to the timing of its fourth quarter and full year 2025 earnings conference call. As previously announced, Gemini will release its fourth quarter and full year 2025 financial results at approximately 4:05 pm ET on Thursday, March 19, 2026. Management will now host a conference call on Friday, March 20, 2026 at 8:30 am ET to discuss the results, rather than on March 19, 2026 as previously announced. The event will be webcast live via our investor relations website https://investors.gemini.com/ or via this link. Parties interested in joining via teleconference can register using this link. After registering, you will be provided dial-in details and a unique dial-in...